Cross Country Healthcare, Inc. (CCRN)
USD 14.13
(-0.91%)
USD 14.13
(-0.91%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.82 Million USD | -107.67% |
| 2022 | 154.14 Million USD | -20.73% |
| 2021 | 194.44 Million USD | 171.76% |
| 2020 | 71.55 Million USD | -23.79% |
| 2019 | 93.89 Million USD | 39.8% |
| 2018 | 67.16 Million USD | -8.75% |
| 2017 | 73.59 Million USD | 10.85% |
| 2016 | 66.39 Million USD | -24.05% |
| 2015 | 87.42 Million USD | 26.55% |
| 2014 | 69.07 Million USD | 13158.93% |
| 2013 | 521 Thousand USD | -97.77% |
| 2012 | 23.39 Million USD | -25.49% |
| 2011 | 31.39 Million USD | -26.22% |
| 2010 | 42.55 Million USD | -21.07% |
| 2009 | 53.91 Million USD | -56.13% |
| 2008 | 122.9 Million USD | 304.5% |
| 2007 | 30.38 Million USD | 41.14% |
| 2006 | 21.52 Million USD | -15.34% |
| 2005 | 25.42 Million USD | -39.85% |
| 2004 | 42.27 Million USD | -54.9% |
| 2003 | 93.73 Million USD | 266.1% |
| 2002 | 25.6 Million USD | -44.6% |
| 2001 | 46.22 Million USD | -70.61% |
| 2000 | 157.27 Million USD | 3357.5% |
| 1999 | -4.82 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -750 Thousand USD | 93.66% |
| 2024 Q2 | -64.86 Million USD | -8548.53% |
| 2023 FY | -11.82 Million USD | -107.67% |
| 2023 Q3 | -8.47 Million USD | -123.06% |
| 2023 Q1 | 145.58 Million USD | -5.55% |
| 2023 Q4 | -11.82 Million USD | -39.49% |
| 2023 Q2 | 36.76 Million USD | -74.74% |
| 2022 Q1 | 232.74 Million USD | 19.7% |
| 2022 Q2 | 216.25 Million USD | -7.08% |
| 2022 FY | 154.14 Million USD | -20.73% |
| 2022 Q4 | 154.14 Million USD | 40.88% |
| 2022 Q3 | 109.41 Million USD | -49.4% |
| 2021 Q4 | 194.44 Million USD | 64.94% |
| 2021 Q3 | 117.89 Million USD | 3.48% |
| 2021 Q2 | 113.92 Million USD | 12.44% |
| 2021 FY | 194.44 Million USD | 171.76% |
| 2021 Q1 | 101.31 Million USD | 41.6% |
| 2020 Q3 | 73.08 Million USD | 13.3% |
| 2020 Q4 | 71.55 Million USD | -2.1% |
| 2020 FY | 71.55 Million USD | -23.79% |
| 2020 Q1 | 78 Million USD | -16.92% |
| 2020 Q2 | 64.5 Million USD | -17.31% |
| 2019 Q1 | 84.69 Million USD | 26.1% |
| 2019 Q2 | 72.36 Million USD | -14.56% |
| 2019 Q4 | 93.89 Million USD | 8.99% |
| 2019 Q3 | 86.14 Million USD | 19.05% |
| 2019 FY | 93.89 Million USD | 39.8% |
| 2018 FY | 67.16 Million USD | -8.75% |
| 2018 Q4 | 67.16 Million USD | 7.42% |
| 2018 Q3 | 62.52 Million USD | -2.59% |
| 2018 Q2 | 64.18 Million USD | -1.73% |
| 2018 Q1 | 65.31 Million USD | -11.25% |
| 2017 FY | 73.59 Million USD | 10.85% |
| 2017 Q4 | 73.59 Million USD | -12.97% |
| 2017 Q3 | 84.56 Million USD | 5906.11% |
| 2017 Q2 | 1.4 Million USD | -93.82% |
| 2017 Q1 | 22.76 Million USD | -65.71% |
| 2016 Q3 | 45.8 Million USD | -34.14% |
| 2016 Q2 | 69.54 Million USD | 0.15% |
| 2016 FY | 66.39 Million USD | -24.05% |
| 2016 Q4 | 66.39 Million USD | 44.96% |
| 2016 Q1 | 69.44 Million USD | -20.57% |
| 2015 Q4 | 87.42 Million USD | 84.35% |
| 2015 Q2 | 63.08 Million USD | -6.97% |
| 2015 FY | 87.42 Million USD | 26.55% |
| 2015 Q3 | 47.42 Million USD | -24.82% |
| 2015 Q1 | 67.8 Million USD | -1.84% |
| 2014 Q2 | 55.5 Million USD | 348.12% |
| 2014 Q1 | 12.38 Million USD | 2277.35% |
| 2014 Q3 | 57.62 Million USD | 3.82% |
| 2014 Q4 | 69.07 Million USD | 19.87% |
| 2014 FY | 69.07 Million USD | 13158.93% |
| 2013 Q3 | -32.19 Million USD | -25.98% |
| 2013 Q2 | -25.55 Million USD | -25.14% |
| 2013 Q1 | -20.42 Million USD | -187.3% |
| 2013 FY | 521 Thousand USD | -97.77% |
| 2013 Q4 | 521 Thousand USD | 101.62% |
| 2012 Q1 | 30.79 Million USD | -1.93% |
| 2012 FY | 23.39 Million USD | -25.49% |
| 2012 Q2 | 30.02 Million USD | -2.5% |
| 2012 Q4 | 23.39 Million USD | -21.16% |
| 2012 Q3 | 29.67 Million USD | -1.16% |
| 2011 Q4 | 31.39 Million USD | -0.79% |
| 2011 Q1 | 42.03 Million USD | -1.22% |
| 2011 Q3 | 31.64 Million USD | -6.79% |
| 2011 Q2 | 33.95 Million USD | -19.23% |
| 2011 FY | 31.39 Million USD | -26.22% |
| 2010 Q1 | 43.94 Million USD | -20.99% |
| 2010 FY | 42.55 Million USD | -21.07% |
| 2010 Q3 | 46.3 Million USD | 0.55% |
| 2010 Q4 | 42.55 Million USD | -8.1% |
| 2010 Q2 | 46.05 Million USD | 4.8% |
| 2009 Q3 | 57.47 Million USD | -29.47% |
| 2009 FY | 53.91 Million USD | -56.13% |
| 2009 Q4 | 55.61 Million USD | -3.24% |
| 2009 Q2 | 81.5 Million USD | -17.14% |
| 2009 Q1 | 98.35 Million USD | -19.98% |
| 2008 Q4 | 122.9 Million USD | -6.73% |
| 2008 Q2 | 29.52 Million USD | -23.53% |
| 2008 Q1 | 38.61 Million USD | 27.09% |
| 2008 FY | 122.9 Million USD | 304.5% |
| 2008 Q3 | 131.77 Million USD | 346.24% |
| 2007 FY | 30.38 Million USD | 41.14% |
| 2007 Q2 | 29 Million USD | 10.04% |
| 2007 Q4 | 30.38 Million USD | -31.12% |
| 2007 Q3 | 44.11 Million USD | 52.09% |
| 2007 Q1 | 26.35 Million USD | 22.44% |
| 2006 FY | 21.52 Million USD | -15.34% |
| 2006 Q4 | 21.52 Million USD | 4.1% |
| 2006 Q3 | 20.68 Million USD | 99.35% |
| 2006 Q2 | 10.37 Million USD | -39.64% |
| 2006 Q1 | 17.18 Million USD | -32.41% |
| 2005 Q4 | 25.42 Million USD | -18.69% |
| 2005 Q3 | 31.27 Million USD | -18.49% |
| 2005 Q1 | 41.57 Million USD | -1.66% |
| 2005 Q2 | 38.37 Million USD | -7.7% |
| 2005 FY | 25.42 Million USD | -39.85% |
| 2004 FY | 42.27 Million USD | -54.9% |
| 2004 Q3 | 60.42 Million USD | -13.13% |
| 2004 Q2 | 69.55 Million USD | -20.49% |
| 2004 Q1 | 87.47 Million USD | -6.68% |
| 2004 Q4 | 42.27 Million USD | -30.03% |
| 2003 Q1 | 13.27 Million USD | -48.16% |
| 2003 Q3 | 100.78 Million USD | -9.13% |
| 2003 FY | 93.73 Million USD | 266.1% |
| 2003 Q2 | 110.9 Million USD | 735.53% |
| 2003 Q4 | 93.73 Million USD | -6.99% |
| 2002 FY | 25.6 Million USD | -44.6% |
| 2002 Q4 | 25.6 Million USD | 68.98% |
| 2002 Q3 | 15.15 Million USD | -46.16% |
| 2002 Q1 | 45.2 Million USD | -2.21% |
| 2002 Q2 | 28.14 Million USD | -37.74% |
| 2001 Q4 | 46.22 Million USD | -74.89% |
| 2001 FY | 46.22 Million USD | -70.61% |
| 2001 Q3 | 184.06 Million USD | 0.0% |
| 2000 FY | 157.27 Million USD | 3357.5% |
| 1999 FY | -4.82 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 100.838% |
| Addus HomeCare Corporation | 110.39 Million USD | 110.714% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 113.228% |
| Amedisys, Inc. | 341.35 Million USD | 103.465% |
| American Oncology Network, Inc. | 99.78 Million USD | 111.852% |
| Astrana Health, Inc. | 27.2 Million USD | 143.47% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 100.813% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | -5239.238% |
| biote Corp. | 25.86 Million USD | 145.719% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 212.746% |
| COMPASS Pathways plc | -187.58 Million USD | 93.695% |
| DocGo Inc. | -12.78 Million USD | 7.522% |
| The Ensign Group, Inc. | 1.36 Billion USD | 100.869% |
| Healthcare Services Group, Inc. | -10.69 Million USD | -10.584% |
| InnovAge Holding Corp. | 56.08 Million USD | 121.086% |
| Assure Holdings Corp. | 14.68 Million USD | 180.554% |
| The Joint Corp. | -2.47 Million USD | -376.999% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 102.736% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | -95.469% |
| ModivCare Inc. | 1.13 Billion USD | 101.04% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 4347.456% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | 391.641% |
| Option Care Health, Inc. | 822.56 Million USD | 101.438% |
| P3 Health Partners Inc. | 83.7 Million USD | 114.129% |
| P3 Health Partners Inc. | 83.7 Million USD | 114.129% |
| The Pennant Group, Inc. | 323.57 Million USD | 103.655% |
| Surgery Partners, Inc. | 2.86 Billion USD | 100.413% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | -290.076% |
| Talkspace, Inc. | -123.9 Million USD | 90.455% |
| Talkspace, Inc. | -123.9 Million USD | 90.455% |
| The Oncology Institute, Inc. | 86.32 Million USD | 113.7% |
| The Oncology Institute, Inc. | 86.32 Million USD | 113.7% |